Fennec Pharmaceuticals Inc (FENC)
Stock-Based Compensation
$6.52M
TTM · Period ending: · USD
FENC Stock-Based Compensation
Latest reported$6.52Mperiod ending
Latest reported$6.52Mperiod ending
FENC TTM Stock-Based Comp ($0.00 → $6.52M)
TTM stock-based compensation
High-resolution chart · PNG
FENC stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 6,515,000 | |
| 6,235,000 | |
| 7,033,000 | |
| 5,635,000 | |
| 5,237,000 | |
| 4,668,000 | |
| 5,061,000 | |
| 4,794,000 | |
| 3,838,000 | |
| 5,456,000 | |
| 5,354,000 | |
| 5,354,000 | |
| 6,376,000 | |
| 4,841,000 | |
| 4,151,000 | |
| 4,204,000 | |
| 3,234,000 | |
| 3,552,000 | |
| 3,749,000 | |
| 3,416,000 | |
| 3,758,000 | |
| 2,975,000 | |
| 2,791,000 | |
| 2,280,000 | |
| 1,356,000 | |
| 2,813,000 | |
| 2,665,000 | |
| 2,578,000 | |
| 2,511,000 | |
| 1,801,000 | |
| 1,825,000 | |
| 1,402,000 | |
| 2,251,000 | |
| 1,708,000 | |
| 1,461,000 | |
| 2,368,000 | |
| 1,292,000 | |
| 656,000 | |
| 628,000 | |
| 234,000 | |
| 202,000 | |
| 101,000 | |
| 97,000 | |
| 116,000 | |
| 174,000 | |
| 503,000 | |
| 627,000 | |
| 529,000 | |
| 503,000 | |
| 193,000 | |
| 60,000 | |
| 341,000 | |
| 303,000 | |
| 291,000 | |
| 291,000 | |
| 64,000 | |
| 218,000 | |
| 250,000 | |
| 250,000 | |
| -179,000 | |
| 49,000 | |
| 2,054,000 | |
| 2,054,000 | |
| 2,430,000 | |
| 2,054,000 | |
| 0 | |
| 0 | |
| 9,000 | |
| 280,000 | |
| 299,000 | |
| 299,000 | |
| 299,000 | |
| 19,000 | |
| 1,241,000 | |
| 1,404,000 | |
| 1,404,000 | |
| 1,404,000 | |
| 163,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -271,005 | |
| -271,005 | |
| -271,005 | |
| -271,005 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |